CELTIC PLC — Share Issue/Capital Change 2019

Aug 30, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7674K

Celtic PLC

30 August 2019

CELTIC PLC

Issued share capital

As a result of the issue of 38,906 Ordinary Shares of 1p each under the Company's scrip dividend reinvestment scheme on 30 August 2019, Celtic PLC's issued share capital as at 30 August 2019 was as follows:

94,242,089	Ordinary Shares of 1p each ("Ordinary Shares")
12,776,907	Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")
15,832,436	Convertible Cumulative Preference Shares of 60p each ("CCP Shares")
670,050,463	Deferred Shares of 1p each ("Deferred Shares")

CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 

The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.

The new Ordinary Shares of 1p each allotted under the scrip scheme have been issued at a notional price of 163.7p each.

Application has been made for the admission of the 38,906 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, will commence on 6 September 2019.

Enquiries:

Company Michael Nicholson, Company Secretary	0141 551 4298
Canaccord Genuity Limited Simon Bridges, Nominated Adviser	020 7523 8350

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOEBSGDIUBXBGCG